[1] World Health Organization. Global tuberculosis report 2021[EB/OL].[2023-09-05].https://www.who.int/publications/digital/global-tuberculosis-report-2021.
[2] World Health Organization. Global tuberculosis report 2022[EB/OL]. [2023-09-05].https://www.who.int/teams/globaltuberculosis-programme/TB-reports/global-tuberculosisreport-2022.
[3] Chan ED, Iseman MD. Multidrug-resistant and extensively drug-resistant tuberculosis: a review[J]. Curr Opin Infect Dis, 2008,21(6):587-595. DOI: 10.1097/QCO.0b013e328319bce6.
[4] Garfein RS, Catanzaro DG, Rodwell TC, et al. Phenotypic and genotypic diversity in a multinational sample of drug-resistant Mycobacterium tuberculosis isolates[J]. Int J Tuberc Lung Dis, 2015,19(4):420-427. DOI: 10.5588/ijtld.14.0488.
[5] European Concerted Action on New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis. Beijing/W genotype Mycobacterium tuberculosis and drug resistance[J]. Emerg Infect Dis, 2006,12(5):736-743. DOI: 10.3201/eid1205.050400.
[6] Casali N, Nikolayevskyy V, Balabanova Y, et al. Evolution and transmission of drug-resistant tuberculosis in a Russian population[J]. Nat Genet, 2014,46(3):279-86. DOI: 10.1038/ng.2878.
[7] Kendall EA, Fofana MO, Dowdy DW. Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis[J]. Lancet Respir Med, 2015,3(12):963-972. DOI: 10.1016/S2213-2600(15)00458-0.
[8] Tang CY, Ong RT. MIRUReader: MIRU-VNTR typing directly from long sequencing reads[J]. Bioinformatics, 2020,36(5):1625-1626. DOI: 10.1093/bioinformatics/btz771.
[9] Mansoori N, Yaseri M, Vaziri F, et al. Genetic diversity of Mycobacterium tuberculosis complex isolates circulating in an area with high tuberculosis incidence: using 24-locus MIRU-VNTR method[J]. Tuberculosis (Edinb), 2018,112:89-97. DOI: 10.1016/j.tube.2018.08.003.
[10] Smittipat N, Billamas P, Palittapongarnpim M, et al. Polymorphism of variable-number tandem repeats at multiple loci in Mycobacterium tuberculosis[J]. J Clin Microbiol, 2005,43(10):5034-5043. DOI: 10.1128/JCM.43.10.5034-5043.2005.
[11] 竺澎波,王楠,孟繁荣,等.以居住地域为基础的广州地区结核病传播链分子流行病学初探[J].国际医药卫生导报,2020,26(12):1649-1654.DOI:10.3760/cma.j.issn.1007-1245.2020.12.001.
[12] Hunter PR, Gaston MA. Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity[J]. J Clin Microbiol, 1988,26(11):2465-2466. DOI: 10.1128/jcm.26.11.2465-2466. 1988.
[13] Sola C, Filliol I, Legrand E, et al. Genotyping of the Mycobacterium tuberculosis complex using MIRUs: association with VNTR and spoligotyping for molecular epidemiology and evolutionary genetics[J]. Infect Genet Evol, 2003,3(2):125-133. DOI: 10.1016/s1567-1348(03)00011-x.
[14] Lange C, Dheda K, Chesov D, et al. Management of drug-resistant tuberculosis[J]. Lancet, 2019,394(10202):953-966. DOI: 10.1016/S0140-6736(19)31882-3.
[15] Gandhi NR, Nunn P, Dheda K, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis[J]. Lancet, 2010,375(9728):1830-1843. DOI: 10.1016/S0140-6736(10)60410-2.
[16] Sharma A, Hill A, Kurbatova E, et al. Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study[J]. Lancet Infect Dis, 2017,17(7):707-715. DOI: 10.1016/S1473-3099(17)30247-5.
[17] Gomez JE, McKinney JD. M. tuberculosis persistence, latency, and drug tolerance[J]. Tuberculosis (Edinb), 2004,84(1-2):29-44. DOI: 10.1016/j.tube.2003.08.003.
[18] Gengenbacher M, Kaufmann SH. Mycobacterium tuberculosis: success through dormancy[J]. FEMS Microbiol Rev, 2012,36(3):514-532. DOI: 10.1111/j.1574-6976.2012.00331.x.
[19] Smith T, Wolff KA, Nguyen L. Molecular biology of drug resistance in Mycobacterium tuberculosis[J]. Curr Top Microbiol Immunol, 2013,374:53-80. DOI: 10.1007/82_2012_279.
[20] Nguyen L. Antibiotic resistance mechanisms in M. tuberculosis: an update[J]. Arch Toxicol, 2016,90(7):1585-604. DOI: 10.1007/s00204-016-1727-6.
[21] Disratthakit A, Meada S, Prammananan T, et al. Genotypic diversity of multidrug-, quinolone- and extensively drug-resistant Mycobacterium tuberculosis isolates in Thailand[J]. Infect Genet Evol, 2015,32:432-439. DOI: 10.1016/j.meegid.2015.03.038.
[22] Rovina N, Karabela S, Constantoulakis P, et al. MIRU-VNTR typing of drug-resistant tuberculosis isolates in Greece[J]. Ther Adv Respir Dis, 2011,5(4):229-236. DOI: 10.1177/1753465811402120.
[23] Khosravi AD, Shahraki AH, Dezfuli SK, et al. Genetic diversity of multidrug-resistant Mycobacterium tuberculosis strains isolated from tuberculosis patients in Iran using MIRU-VNTR technique[J]. Kaohsiung J Med Sci, 2017,33(11):550-557. DOI: 10.1016/j.kjms.2017.06.011.
[24] 王楠,吴玲,牛群,等.211例中国南方地区结核分枝杆菌48-locus MIRU-VNTR基因分型分析[J].国际医药卫生导报,2019,25(9):1374-1378,1383.DOI:10.3760/cma.j.issn.1007-1245.2019.09.007.
|